Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen

Roberta ROLLA; M. Vidali; S. Meola; P. Pollarolo; M. R. Fanello; C. Nicolotti; L. Forti; G. Borra; F. D’Agostino; V. Rossi; ALABISO Oscar; BELLOMO Giorgio

Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen

Roberta ROLLA
, M. Vidali
, S. Meola
, P. Pollarolo
, M. R. Fanello
, C. Nicolotti
, L. Forti
, G. Borra
, F. D’Agostino
, V. Rossi
, ALABISO Oscar
, BELLOMO Giorgio

Department of Health Sciences

Research output: Contribution to conference › Paper

Original language	Italian
Publication status	Published - 1 Jan 2011
Event	IFCC-WorldLab 21st International Congress of Clinical Chemistry and Laboratory Medicine - Berlin, Germany Duration: 1 Jan 2011 → …

Conference

Conference	IFCC-WorldLab 21st International Congress of Clinical Chemistry and Laboratory Medicine
City	Berlin, Germany
Period	1/01/11 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

ROLLA, R., Vidali, M., Meola, S., Pollarolo, P., Fanello, M. R., Nicolotti, C., Forti, L., Borra, G., D’Agostino, F., Rossi, V., Oscar, ALABISO., & Giorgio, BELLOMO. (2011). Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen. Paper presented at IFCC-WorldLab 21st International Congress of Clinical Chemistry and Laboratory Medicine, Berlin, Germany.

@conference{272e89e816d84ef890f5811c05cfeccd,

title = "Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen",

author = "Roberta ROLLA and M. Vidali and S. Meola and P. Pollarolo and Fanello, \{M. R.\} and C. Nicolotti and L. Forti and G. Borra and F. D{\textquoteright}Agostino and V. Rossi and ALABISO Oscar and BELLOMO Giorgio",

year = "2011",

month = jan,

day = "1",

language = "Italian",

note = "IFCC-WorldLab 21st International Congress of Clinical Chemistry and Laboratory Medicine ; Conference date: 01-01-2011",

}

ROLLA, R, Vidali, M, Meola, S, Pollarolo, P, Fanello, MR, Nicolotti, C, Forti, L, Borra, G, D’Agostino, F, Rossi, V, Oscar, ALABISO & Giorgio, BELLOMO 2011, 'Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen', Paper presented at IFCC-WorldLab 21st International Congress of Clinical Chemistry and Laboratory Medicine, Berlin, Germany, 1/01/11.

TY - CONF

T1 - Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen

AU - ROLLA, Roberta

AU - Vidali, M.

AU - Meola, S.

AU - Pollarolo, P.

AU - Fanello, M. R.

AU - Nicolotti, C.

AU - Forti, L.

AU - Borra, G.

AU - D’Agostino, F.

AU - Rossi, V.

AU - Oscar, ALABISO

AU - Giorgio, BELLOMO

PY - 2011/1/1

Y1 - 2011/1/1

UR - https://iris.uniupo.it/handle/11579/29447

M3 - Contributo in Atti di Convegno

T2 - IFCC-WorldLab 21st International Congress of Clinical Chemistry and Laboratory Medicine

Y2 - 1 January 2011

ER -

Association between ultrarapid CYP2D6 polymorphisms and adverse drug reactions among women with breast cancer treated with tamoxifen

Conference

UN SDGs

Other files and links

Cite this